| (高级)医药代表 /(资深)产品专员 |
Haikou (Hainan Province) |
China |
International |
Innovative Medicines |
Sales |
17 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
17 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
17 Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italy |
Operations |
Innovative Medicines |
Quality |
17 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Oncology MSL |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Customer Experience and Omnichannel Manager |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
18 Oktober 2024 |
| Chef, Éducation médicale - Cancer du sein |
Montreal |
Canada |
International |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Head Clinical Development Business Solutions |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| (Sr.) Medical Advisor, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| (高级)地区经理 |
Huhehaote (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| (高级)地区经理 |
Chifeng (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| (高级)大区经理 |
Zhengzhou (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Yangzhou (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
18 Oktober 2024 |
| SSO Finance Specialist |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
20 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Ningbo (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
20 Oktober 2024 |
| (高级)地区经理 |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
20 Oktober 2024 |
| Patient Journey Partner Lead GTx |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
21 Oktober 2024 |
| Chef, Communications corporatives |
Montreal |
Canada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
21 Oktober 2024 |
| Chef principal, Planification de nouveaux produits |
Montreal |
Canada |
International |
Innovative Medicines |
Market Access |
21 Oktober 2024 |
| Gestionnaire des opérations des PSP |
Montreal |
Canada |
International |
Innovative Medicines |
Marketing |
21 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Sales |
21 Oktober 2024 |
| 县域主任(主管) |
Pingdingshan (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
21 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
22 Oktober 2024 |
| Medical Science Liaison |
Novosibirsk |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
22 Oktober 2024 |
| Специалист по системе качества |
St. Petersburg (City) |
Russian Fed. |
Operations |
Innovative Medicines |
Quality |
22 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| Capability Building Manager |
Milano |
Italy |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| Procure to Pay Business Partner US Temporary |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
22 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| Recent Bachelor or Master Graduate |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
Others |
22 Oktober 2024 |
| Assistant(e) de Coordination Accès au Marché H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Market Access |
22 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Anqing (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
23 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
23 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Anqing (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
23 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
23 Oktober 2024 |
| Cardiovascular Therapeutic Area Head |
Warsaw |
Poland |
International |
Innovative Medicines |
Commercial & General Management |
23 Oktober 2024 |
| Business Planning Analysis Manager / Analyst |
INSURGENTES |
Mexico |
Biomedical Research |
CTS |
Audit & Finance |
23 Oktober 2024 |